Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
Background: Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. There is a need for more effective, safe, and well-tolerated drugs. Linezolid is a repurposed oxazolidinone antimicrobial with...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Medicine
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Optimising linezolid use for drug-resistant tuberculosis: pharmacokinetics, toxicity, and resistance
- Extensively drug resistant tuberculosis in South Africa
- The epidemiology and management of drug-resistant tuberculosis in childhood
- Antimicrobial resistance mechanisms of linezolid resistant staphylococci and enterococci collected in Gauteng, South Africa
- Efficacy and safety of novel and repurposed drugs for the treatment of drug-resistant tuberculosis
- The evolution of the Mycobacterium tuberculosis proteome in response to the development of drug resistance
- Resistance to new tuberculosis drugs